A drug known as the “female viagra” has been approved by US health regulators, in what experts say is the biggest advance in women’s sexual health since the the advent of the Pill in the 1960s.
Addyi, the first-ever pill to treat low libido in women, won the backing of the Food and Drug Administration (FDA) and will soon be widely available in America.  The drug will only be available through certified health care professionals and pharmacies due to its safety issues.

British women may have to wait years for a similar treatment to arrive in the UK.
While men have dozens of drug options to address male sexual dysfunction, Addyi is the first approved drug to help women.
“This is the biggest breakthrough in women’s sexual health since the advent of the Pill,” said Sally Greenberg, executive director of the National Consumers League.
“Men have 26 different drugs available to treat sexual dysfunction. Now, with this drug’s approval, women finally have one.”
The drug, which is produced by Sprout Pharmaceuticals, is intended to treat hypoactive sexual desire disorder (HSDD) – where a sufferer’s lack of sexual desire is causing them distress.
Around one in ten women are estimated to suffer from HSDD at some point in their lives.
Addyi is taken once a day in the form of a pink pill and regulators said it was only safe for women have not reached menopause. A warning on its boxes also say it is not suitable for women who drink alcohol.
It will go on sale from October 17 in the US.
The drug has not yet been submitted for approval by either the European Medicines Agency or Britain’s Medicines and Healthcare products Regulatory Agency (MHRA), meaning it could be years before Addyi or an equivalent is available in the UK.
A spokeswoman for Sprout Pharmaceuticals said the company was “committed to working closely” with international regulators to make the drug available outside of the US.
A drug to treat HSDD brought about by surgery was approved at the European level in 2006 but its manufacturers withdrew in 2012 because the product was not commercially viable.

Telegraph Uk


Ad:See How you can turn $500 into $10,000 Click HERE For Details.
SHARE